Sinovation Medical Recieves ￥10M Strategic Investment from Medtronic China Fund

According to VCBeat, Sinovation Medical Technology Co., Ltd. ("Sinovation Medical") has got a strategic investment of tens of millions from Medtronic China Fund. In the future, the two companies will explore multi-level strategic cooperation in neurosurgery.

Founded in 2015, Sinovation Medical aims to promote the revolution of neurosurgical robots. Since its establishment five years ago, two products of Sinovation Medical have obtained the third-class medical device registration certified by NMPA, two products entered "Green Channel" for innovative medical devices (the neurosurgical robot and the magnetic resonance-guided laser ablation system called LITT, both the only products entering the special registration process in China among their counterparts).

More than 40 hospitals have used the devices developed by Sinovation Medical in robotic surgery routinely. There are more than 1000 neurosurgery clinical experts using those products. The robotic surgery planning software and surgical navigation software are more widely used. According to incomplete statistics, the number of relevant surgeries has exceeded 10,000.

At present, the neurosurgical robot has the highest usage in stereotactic electroencephalography (SEEG), and the neurosurgical robot of Sinovation Medical has realized routine application in this field.

For refractory epilepsy, doctors need to place deep brain electrodes into the patient's skull to collect electrical signals. The reason for the high penetration rate of surgical robots is that SEEG requires up to 10 or more electrodes in the surgery, and neurosurgical robots can significantly reduce the operation time, improve the accuracy and achieve good stability for multiple implantations.

Neurosurgical robots are expected to expand their indications. Among them, the increasing usage in deep electrode implantation for Parkinson's disease attracts more and more attention.

At present, the application of neurosurgical robots in deep brain stimulation (DBS) worldwide is at the stage of exploration. Sinovation Medical has cooperated with more than 10 clinical institutions for a large number of researches. It has formed a comprehensive solution of the correlated surgical software, supporting instruments, surgical procedure specification and other aspects. Since the year of 2020, the demand in DBS of Sinovation Medical's surgical robots have increased rapidly.

Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie. The company develops and manufactures devices and therapies to treat more than 30 chronic diseases.

Medtronic China Fund was established in Suzhou in 2016, committed to investing in early-stage Chinese medical technology enterprises and overseas innovative technologies that meet the needs of the Chinese market, accelerating the transformation and implementation of innovative technologies, and providing solutions for local medical needs.